Biofrontera (BFRI) Other Non-Current Liabilities (2020 - 2025)

Biofrontera's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $9000.0 for Q4 2025.

• On a quarterly basis, Other Non-Current Liabilities fell 99.28% year-over-year to $9000.0 in Q4 2025; TTM through Dec 2025 was $9000.0, a 99.28% decrease from a year earlier, with the FY2025 full-year figure at $9000.0, down 99.28% from the prior year.
• Other Non-Current Liabilities fell to $9000.0 in Q4 2025 per BFRI's latest filing, from $12000.0 in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $12.9 million in Q4 2021 and bottomed at $9000.0 in Q4 2025.
• The 5-year median for Other Non-Current Liabilities is $4.9 million (2022), against an average of $5.2 million.
• Across the five-year window, Other Non-Current Liabilities slumped 99.84% in 2022 and jumped 19947.62% in 2023, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $12.9 million in 2021, then slumped by 99.84% to $21000.0 in 2022, then soared by 19947.62% to $4.2 million in 2023, then slumped by 70.31% to $1.2 million in 2024, then tumbled by 99.28% to $9000.0 in 2025.
• Per Business Quant, the three latest BFRI Other Non-Current Liabilities figures stand at $9000.0 (Q4 2025), $12000.0 (Q3 2025), and $14000.0 (Q2 2025).